Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nova MD vs RxSaludable

Nova MD
Graded #174

Higher grade

vs+3.700000000000003
RxSaludable
Graded #259

Lower grade

The verdict

Nova MD takes it — 66.9/100 to 63.2/100.

Nova MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNova MD +17
68
51
Dose & formulationRxSaludable +13
64
77
Clinical oversightEven
82
82
Labs & monitoringNova MD +1
54
53
FulfillmentRxSaludable +8
68
76
Contract termsNova MD +35
55
20
Nova MD · left barRxSaludable · right bar

The numbers

MetricNova MDRxSaludable
WeighScore66.9/10063.2/100
GradeCC
Scorecard rank#174#259
Semaglutide$175/mo (compounded)$179/mo (compounded)
Tirzepatide$225/mo (compounded)$269/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Nova MD

Graded #174 · C

Strengths

  • On-page pricing published for all four SKUs (semaglutide and tirzepatide, 1- and 3-month)
  • $125/mo semaglutide and $199/mo tirzepatide 3-month plans rank among the cheapest in the market
  • $50 off first tirzepatide order shown publicly
  • Explicit microdose / low-dose program for both semaglutide and tirzepatide
  • Broader menu (sermorelin, NAD+, glutathione, enclomiphene) for longevity alongside GLP-1

Where it loses points

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy not named — only 'accredited facilities'
  • LegitScript certification not confirmed (only 'Licensed US Providers' claims)
  • Per-state availability not listed
  • Compounded only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic
RxSaludable

Graded #259 · C

Strengths

  • Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
  • Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
  • LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
  • Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime

Where it loses points

  • Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
  • Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
  • No legal entity name or explicit state-coverage list published on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard